» Articles » PMID: 39345245

Relationship Between Coronary Artery Disease with Dyslipidaemia and Trace Mineral Intake: a Cross-sectional Analysis of the Shika Study

Abstract

Although the relationship between dyslipidaemia (DL) and coronary artery disease (CAD) or between trace minerals intake and CAD is well known separately, the exact nature of this relationship remains unknown. We hypothesize that the relationship between trace mineral intake and CAD may differ depending on whether or not the individual has DL. The present study analysed the relationships among trace mineral intake, DL, and CAD in middle-aged and older adults living in Shika town, Ishikawa prefecture, Japan. This study included 895 residents following the exclusion of those with genetic risk carriers for familial hypercholesterolemia. Trace mineral intake was evaluated using the brief-type self-administered diet history questionnaire. Interactions were observed between DL and CAD with zinc ( = 0.004), copper ( = 0.010), and manganese intake ( < 0.001) in a two-way analysis of covariance adjusted for covariates such as sex, age, body mass index, and current smokers and drinkers. Multiple logistic regression analysis showed that zinc (odds ratio (OR): 0.752; 95% confidence interval (CI): 0.606, 0.934; = 0.010), copper (OR: 0.175; 95% CI: 0.042, 0.726; = 0.016), and manganese (OR: 0.494; 95% CI: 0.291, 0.839; = 0.009) were significant independent variables for CAD in the dyslipidaemic group. The present results suggest that DL with a low trace mineral intake is associated with CAD. Further longitudinal studies are required to confirm this relationship.

References
1.
Duggan J, Peters A, Trachiotis G, Antevil J . Epidemiology of Coronary Artery Disease. Surg Clin North Am. 2022; 102(3):499-516. DOI: 10.1016/j.suc.2022.01.007. View

2.
Mihaila R . Pragmatic Analysis of Dyslipidemia Involvement in Coronary Artery Disease: A Narrative Review. Curr Cardiol Rev. 2019; 16(1):36-47. PMC: 7393591. DOI: 10.2174/1573403X15666190522100041. View

3.
Prasad A . Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009; 12(6):646-52. DOI: 10.1097/MCO.0b013e3283312956. View

4.
Lynch C, Patson B, Goodman S, Trapolsi D, Kimball S . Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR. Am J Physiol Endocrinol Metab. 2001; 281(1):E25-34. DOI: 10.1152/ajpendo.2001.281.1.E25. View

5.
Ranasinghe P, Wathurapatha W, Ishara M, Jayawardana R, Galappatthy P, Katulanda P . Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond). 2015; 12:26. PMC: 4523910. DOI: 10.1186/s12986-015-0023-4. View